关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 3 2 9 3 2 0 0 位浏览者
您当前的位置:首页 >> 正文

液相色谱-质谱联用同时测定大鼠血浆中替硝唑、达克罗宁和氯己定的浓度及其药动学研究

Simultaneous determination of tinidazole,dyclonine and chlorhexidine in rat plasma by HPLC-MS/MS and its application in the pharmacokinetic research

分类号:
出版年·卷·期(页码):2014,34 (1):0-0
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:建立大鼠血浆中替硝唑、达克罗宁和氯己定的HPLC-MS/MS定量分析方法。方法:采用固相萃取预处理血浆样品。使用Phenomenex Gemini C18色谱柱(50 mm×2.0 mm,5 μm),以甲醇-10 mmol·L-1甲酸铵-甲酸(56:44:0.2)为流动相,流速0.2 mL·min-1,柱温25℃,酚妥拉明为内标;通过电喷雾离子化四极杆串联质谱,以正离子多反应监测方式(MRM)检测,用于定量分析的离子反应分别为m/z 247.9→m/z 82.0(替硝唑)、m/z 290.0→m/z 98.0(达克罗宁)、m/z 505.0→m/z 335.5(氯己定)、m/z 282.1→m/z 212.0(酚妥拉明)。结果:测定替硝唑、达克罗宁和氯己定的线性范围均为2~1000 ng·mL-1,最低定量限为2 ng·mL-1,提取回收率均 > 81.3%,日内RSD均 < 11.0%,日间RSD均 < 14.1%,准确度在-7.2%~2.9%范围内;替硝唑、达克罗宁、氯己定Tmax分别为(1.50±0.93)、(1.50±0.43)、(1.50±1.05)h,Cmax分别为(111.23±39.14)、(42.17±23.15)、(8.95±6.45) ng·mL-1t1/2分别为(5.09±2.17)、(5.93±1.93)、(7.34±6.28)h,AUC0-t分别为(804.52±87.66)、(145.57±21.86)、(99.31±24.01) ng·h·mL-1结论:该方法快速、灵敏、准确,可用于替硝唑、达克罗宁和氯己定在大鼠体内的药动学研究。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To develop and validate a rapid and sensitive HPLC-MS/MS method for simultaneous determination of tinidazole,dyclonine and chlorhexidine in rat plasma. Methods: The plasma samples were pretreated by the solid phase extraction (SPE) method.Separation was achieved on a Phenomenex Gemini C18 column (50 mm×2.0 mm,5 μm) using an isocratic mobile phase system composed of methanol-ammonium formate (10 mmol·L-1)-formic acid (56: 44: 0.2) at a flow rate of 0.2 mL·min-1.The column temperature was controlled at 25℃.The internal standard was phentolamine mesylate.Analytes were determined by tandem mass spectrometry with electrospray positive ionization and multiple-reaction monitoring (MRM) mode.The monitoring ions were m/z 247.4→m/z 82.0 for tinidazole,m/z 290.0→m/z 98.0 for dyclonine,m/z 505.0→m/z 335.5 for chlorhexidine and m/z 282.1→m/z 212.0 for phentolamine. Results: The calibration curves were linear in the range of 2-1000 ng·mL-1 and LLOQ were all 2 ng·mL-1for the three compounds.The mean extraction recoveries were all above 81.3%.The intra-day and inter-day RSD values were less than 11.0% and 14.1%,respectively.The RE values were all within the range of-7.2%-2.9%.The main pharmacokinetic parameters oftinidazole, dyclonine, chlorhexidine were as follows: Tmax (1.50±0.93), (1.50±0.43) and (1.50±1.05)h; Cmax (111.23±39.14), (42.17±23.15) and (8.95±6.45) ng·mL-1; t1/2 (5.09±2.17), (5.93±1.93) and (7.34±6.28) h;AUC0-t (804.52±87.66), (145.57±21.86) and (99.31±24.01) ng·h·mL-1; respectively. Conclusion: The method is rapid,sensitive,accurate and can be applied to the pharmacokinetic research of tinidazole,dyclonine and chlorhexidine in rat plasma.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 1639位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn